XRN completed a dramatic corporate transformation including a name change from Global Medical REIT, a 1-for-5 reverse stock split, and massive debt reduction of 92% while achieving profitability.
The company underwent a comprehensive restructuring that fundamentally altered its capital structure and business identity. The reverse stock split combined with the name change from Global Medical REIT suggests either a strategic pivot or potential distress situation that required dramatic action to maintain listing compliance or investor confidence.
XRN's financials show a remarkable turnaround with net income swinging from a $2.5M loss to an $18.3M profit, driven primarily by a massive 92% debt reduction from $14.4M to $1.2M that likely eliminated significant interest burden despite overall interest expense still increasing 22.4%. Cash position strengthened by 33% to $9.1M, though current assets declined 71%, suggesting the company may have liquidated assets or restructured operations to achieve debt paydown and profitability. The overall picture signals a major balance sheet restructuring that has restored profitability but raises questions about the sustainability of operations with reduced asset base.
Net income grew 834% — bottom-line growth signals improving overall business health.
Current liabilities surged 146.5% — significant near-term obligations; verify ability to meet short-term debt.
Debt reduced 92% — deleveraging strengthens balance sheet and reduces financial risk.
Current assets declined 71.4% — monitor working capital adequacy and short-term liquidity.
Cash position surged 33.3% — strong cash generation or capital raise providing significant financial cushion.
Interest costs rose 22.4% — monitor debt levels and coverage ratio in rising rate environment.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →